ENTITY

TxCell SA (TXCL FP)

Analysis

Health Care • France

TxCell SA researches and develops biotechnological products. The Company offers cell-based immunotherapies for the treatment of chronic inflammatory, bowel, joint, and neurological diseases.

Refresh

Focused

No publications yet

There aren’t any buy-side reports right now

Back to "All"

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00